Top news of the week: 11.08.2021.
Companies And Industries
Science pioneer, pharma research chief, global health advocate and biotech entrepreneur Tadataka ‘Tachi’ Yamada has died
Tadataka Yamada, a towering physician-scientist who made his name in academia before transforming drug development at GSK and developing vaccines for malaria and meningitis at the Gates ...
Philip Morris' biopharma addiction ramps up, as heart attack biotech OtiTopic joins cigarette maker on 'Beyond Nicotine' journey
Philip Morris first starting selling tobacco products to the public all the way back in 1847, but, more than 170 years later, the company has read the tea leaves and the future is ...
Billions in new research funding sparks a lobbying frenzy among patient advocates
Patient groups are scrambling to ensure they benefit from the gold rush of new research dollars and high-profile attention.
Gene therapy specialist bluebird exits “untenable” European market
Europe's pricing and reimbursement environment is too hostile for gene therapy developers, says bluebird bio, which is pulling out and focusing on the US
Why Join Us
ACCESSION THERAPEUTICS is a new biotech company developing 3rd generation immune oncology treatments. Its unique delivery technology, enabling access to solid tumours and …
SK Bio’s COVID vaccine will start phase 3 study versus AZ jab
Head-to-head trial will compare SK Bioscience's COVID-19 vaccine GB510 against the AstraZeneca shot; South Korean biotech says it is hoping to launch in the first half of 2022
Good Day BIO: SEC approves board diversity proposal
It’s a new week—and the SEC approved an important Nasdaq proposal that will improve diversity and inclusion in public companies. We tell you how you can get more details, plus look at why ...
Researchers chemically synthesize a mirror-image of Pfu DNA polymerase
A trio of researchers working at the School of Life Sciences, Tsinghua-Peking Center for Life Sciences, has chemically synthesized a mirror-image of Pfu DNA polymerase. In their paper ...